Company / Operating Cash Flow per Share
IRADIMED CORP Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.96
FY2025
5-year range
$0.83 / $2.02
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
#92 of 161
Health Care
What the data says
At $1.96, IRADIMED CORP's operating cash flow per share ranks #92 of 161 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.23 in FY2016 to $2.02 in FY2024.
Based on SEC 10-K filings.
1.96 in FY2025 with a 5-year CAGR of +31.8%.
Improved from $1.07 to $1.96 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +31.8%
- 10-Year CAGR
- -
Sector benchmark
#92 of 161 in Health CareTop 57% of 161This company $1.96 Sector average $6.64
▼
-70.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 3.0% year-over-year.
- Ranks #92 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.96 | -3.0% |
| FY2024 | $2.02 | +89.3% |
| FY2023 | $1.07 | +19.6% |
| FY2022 | $0.89 | +7.6% |
| FY2021 | $0.83 | +68.1% |
| FY2020 | $0.49 | -46.9% |
| FY2019 | $0.93 | +4.9% |
| FY2018 | $0.89 | +24.4% |
| FY2017 | $0.71 | +208.3% |
| FY2016 | $0.23 | -3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026